Sofie | search
Click here to view Sofie news from 60+ newspapers.
Bookmark or Share- FAPI Development - SOFIEABX is SOFIE’s partner of choice for our FAPI precursor production. ABX has successfully completed the manufacture and shipment of the first stocks of FAPI precursor material, enabling our distribution of precursor and reference standards under MTAs to multiple approved users in the US and EU.
- Home - SOFIESOFIE network expands production of 18F-FAPI-74 2024 Was a Banner Year for FAPI Tech Transfer! Thanks to the diligent efforts of our team, 18F-FAPI-74 production is now live at FIVE [...]
- Network - SOFIESOFIE has built a high-capacity PET radiopharmaceutical network capable of delivering large volumes of products to as many patients as possible. Our product lines include FDG, Pylarify, Neuraceq, and other clinical trial products.
- Access - SOFIESOFIE has engaged with many academic institutions globally to unlock FAPI’s clinical utility potential. We are pleased to support your interest in the use of FAPI as a diagnostic or companion diagnostic tool.
- Trilantic North America Completes Strategic Growth Investment ... - SOFIENEW YORK (June 4, 2024) – Trilantic North America, a growth-focused middle market private equity firm, announced today that it has made a substantial growth investment in SOFIE Biosciences (“SOFIE” or the “Company”), a founder-led radiopharmacy and contract development and manufacturing organization.
More
